RETRACTION: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma) (Retraction of Vol 23, Pg 1947, 2017)

被引：1
|
作者：
Song, Hao
Chi, Yuchun
Shi, Chunling
Xu, Miao
Yu, Benxia
Zhang, Zhongsheng
机构：
来源：
MEDICAL SCIENCE MONITOR | 2018年 / 24卷
关键词：
D O I：
10.12659/MSM.912715
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：5904 / 5904
页数：1
相关论文
共 37 条
  • [1] RETRACTED: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma) (Retracted Article)
    Yu, Benxia
    Zhang, Zhongsheng
    Song, Hao
    Chi, Yuchun
    Shi, Chunling
    Xu, Miao
    [J]. MEDICAL SCIENCE MONITOR, 2017, 23 : 1947 - 1955
  • [2] Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer
    Terlevic, Robert
    Balja, Melita Peric
    Tomas, Davor
    Skenderi, Faruk
    Kruslin, Bozo
    Vranic, Semir
    Demirovic, Alma
    [J]. ANNALS OF DIAGNOSTIC PATHOLOGY, 2019, 38 : 62 - 66
  • [3] Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5?
    Pisarek, Hanna
    Pawlikowski, Marek
    Kunert-Radek, Jolanta
    Winczyk, Katarzyna
    [J]. ENDOKRYNOLOGIA POLSKA, 2010, 61 (02) : 178 - 181
  • [4] Immunohistochemical expression of somatostatin receptors SSTR2A and SSTR5 in 299 pituitary adenomas
    Fuchs, Talia L.
    Sioson, Loretta
    Sheen, Amy
    Clarkson, Adele
    Gill, Anthony J.
    [J]. PATHOLOGY, 2018, 50 (04) : 472 - 474
  • [5] Detection of Somatostatin Receptors, SSTR2A and SSTR5, in TSH Producing Pituitary Adenomas: Patho-Clinical Correlation
    Takei, M.
    Kajiya, H.
    Inomoto, C.
    Takekoshi, S.
    Teramoto, A.
    Osamura, R. Y.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 120A - 120A
  • [6] Detection of Somatostatin Receptors, SSTR2A and SSTR5, in TSH Producing Pituitary Adenomas: Patho-Clinical Correlation
    Takei, M.
    Kajiya, H.
    Inomoto, C.
    Takekoshi, S.
    Teramoto, A.
    Osamura, R. Y.
    [J]. MODERN PATHOLOGY, 2009, 22 : 120A - 120A
  • [7] Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms
    Buscail, L.
    Esteve, J.-P.
    Saint-Laurent, N.
    Bertrand, V.
    [J]. Proceedings of the National Academy of Sciences of the United States of America, 1995, 92 (05):
  • [8] INHIBITION OF CELL-PROLIFERATION BY THE SOMATOSTATIN ANALOG RC-160 IS MEDIATED BY SOMATOSTATIN RECEPTOR SUBTYPES SSTR2 AND SSTR5 THROUGH DIFFERENT MECHANISMS
    BUSCAIL, L
    ESTEVE, JP
    SAINTLAURENT, N
    BERTRAND, V
    REISINE, T
    OCARROLL, AM
    BELL, GI
    SCHALLY, AV
    VAYSSE, N
    SUSINI, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) : 1580 - 1584
  • [9] Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma
    Alexander, Natasha
    Marrano, Paula
    Thorner, Paul
    Naranjo, Arlene
    Van Ryn, Collin
    Martinez, Daniel
    Batra, Vandana
    Zhang, Libo
    Irwin, Meredith S.
    Baruchel, Sylvain
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (03) : 222 - 227
  • [10] Somatostatin receptor subtypes SSTR2 and SSTR5 couple negatively to an L-type Ca2+ current in the pituitary cell line AtT-20
    Tallent, M
    Liapakis, G
    OCarroll, AM
    Lolait, SJ
    Dichter, M
    Reisine, T
    [J]. NEUROSCIENCE, 1996, 71 (04) : 1073 - 1081
1234